Business disputes are expected to make up the bulk of cases at Hong Kong’s new International Organisation for Mediation (IOMed), which plans to accelerate its outreach efforts entering its second year of operation, secretary general Teresa Cheng Yeuk-wah said in an interview. Commercial cases account for up to 95 per cent of all disputes worldwide, while no more than 5 per cent involve states, and IOMed “naturally” expected a similar spread for its own caseload, Cheng said on the sidelines of...

In September, Chief Executive John Lee Ka-chiu unveiled the city’s first five-year plan along with his policy address, highlighting Hong Kong’s strategic role in promoting the greater use of the yuan outside mainland China as a key priority. In the third part of a four-part series on the globalisation of the yuan, Xinmei Shen explores how Hong Kong is testing the interoperability of the e-CNY and other digital assets in an effort to broaden the currency’s international appeal. In a US Senate...

An array of Chinese drug makers showcased positive trial results for new cancer treatments at a major European medical conference, underscoring the expanding international influence of China’s biotech sector. Domestic innovative drugs, particularly antibody-drug conjugates (ADCs), delivered impressive data across multiple tumour types at the European Society for Medical Oncology (Esmo) Congress, with some early-stage data further showing the country’s “innovation capabilities”, said analysts...